Can tryptophan oxidation lead to lower tryptophan level in diabetes? A commentary on "Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: Inhibition by pyridoxamine"

Free Radical Biology and Medicine

Volumn 44, Issue 7, 2008, Pages 1273-1275

  Jain, Sushil K ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Free radicals

Indexed keywords

GLYCOSYLATED PROTEIN; PYRIDOXAMINE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL CULTURE; CELL METABOLISM; DIABETES MELLITUS; DIABETIC PATIENT; GLUCOSE METABOLISM; GLYCATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION;

EID: 40949091390     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.01.005     Document Type: Note

References (29)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
2. Jain S.K. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J. Biol. Chem. 264 (1989) 21340-21345
3. Jay D., Hitomi H., and Griendling K.K. Oxidative stress and diabetic cardiovascular complications. Free Radic. Biol. Med. 40 (2006) 183-192
4. Jain S.K., Kannan K., and Lim G. Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic. Biol. Med. 25 (1998) 1083-1088
5. Jain S.K., and McVie R. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 48 (1999) 1850-1855
6. Singh U., Devaraj S.S., and Jialal I. Vitamin E, oxidative stress and inflammation. Annu. Rev. Nutr. 25 (2005) 151-174
7. Chang T.I., Horal M., Jain S.K., Wang F., Patel R., and Loeken M.R. Oxidant regulation of gene expression and neural tube development: insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 46 (2003) 538-545
8. Chetyrkin S.V., Mathis M.E., Ham A.J.L., Hachey D.L., Hudson B.G., and Voziyan P.A. Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine. Free Radic. Biol. Med. 44 (2008) 1276-1285
9. Herrera R., Manjarrez G., Nishimura E., and Hernandez J. Serotonin-related tryptophan in children with insulin-dependent diabetes. Pediatr. Neurol. 28 (2003) 20-23
10. Manjarrez G.G., Herrera Marques J.R., Molina Hernandez A., and Hernandez J. Alteraciones de la neurotransmision serotoninergica cerebral inducida por diabetes mellitus tipo 1. Rev. Invest. Clin. 51 (1999) 293-302
11. Saxena A.K., Saxena P., Wu X., Obrenovich M., Weiss M.F., and Monnier V.M. Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: relevance to diseases of glycoxidative stress. Biochem. Biophys. Res. Commun. 260 (1999) 332-338
12. Hamblin M., Friedman D.B., Hill S., Caprioli R.M., Smith H.M., and Hill M.F. Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. J. Mol. Cell. Cardiol. 42 (2007) 884-895
13. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 3rd ed. 936 (1999), Oxford Univ. Press, London
14. Coussons P.J., Jacoby J., McKay A., Kelly S.M., Price N.C., and Hunt J.V. Glucose modification of human serum albumin: a structural study. Free Radic. Biol. Med. 22 (1997) 1217-1227
15. Ogata N. Denaturation of protein by chlorine dioxide: oxidative modification of tryptophan and tyrosine residues. Biochemistry 46 (2007) 4898-4911
16. Rogers K.S., and Mohan C. Vitamin B6 metabolism and diabetes. Biochem. Med. Metab. Biol. 52 (1994) 10-17
17. Booth A.A., Khalifah R.G., and Hudson B.G. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end products: comparison with aminoguanidine. Biochem. Biophys. Res. Commun. 220 (1996) 113-119
18. Booth A.A., Khalifah R.G., Todd P., and Hudson B.G. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs): novel inhibition of postAmadori glycation pathways. J. Biol. Chem. 272 (1997) 5430-5437
19. Voziyan P.A., Metz T.O., Baynes J.W., and Hudson B.G. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J. Biol. Chem. 277 (2002) 3397-3403
20. Degenhardt T.P., Alderson N.L., Arrington D.D., Beattie R.J., Basgen J.M., Steffes M.W., Thorpe S.R., and Baynes J.W. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int. 61 (2002) 939-950
21. Stitt A., Gardiner T.A., Alderson N.L., Canning P., Frizzell N., Duffy N., Boyle C., Januszewski A.S., Chachich M., Baynes J.W., and Thorpe S.R. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51 (2002) 2826-2832
22. Alderson N.L., Chachich M.E., Youssef N.N., Beattie R.J., Nachtigal M., Thorpe S.R., and Baynes J.W. The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. Kidney Int. 63 (2003) 2123-2133
23. Metz T.O., Alderson N.L., Chachich M.E., Thorpe S.R., and Bayes J.W. Pyridoximine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications. J. Biol. Chem. 278 (2003) 42012-42019
24. Solomon L.R., and Cohen K. Erythrocyte oxygen transport and metabolism and effect of vitamin B6 therapy in type II diabetes mellitus. Diabetes 38 (1989) 881-886
25. Cohen K.L., Gorecki G.A., Silverstein S.B., Ebersole J.S., and Solomon L.R. Effect of pyridoxine (vitamin B6) on diabetic patients with peripheral neuropathy. J. Am. Podiatry Assoc. 74 (1984) 394-397
26. 2-treated U937 monocytes. Free Radic. Biol. Med. 36 (2004) 423-428
27. Jain A., Lim G., Langford M., and Jain S.K. Effect of high-glucose levels on protein oxidation in cultured lens cells and in crystalline and albumin solution and its inhibition by vitamin B6 and N-acetylcysteine: its possible relevance to cataract formation in diabetes. Free Radic. Biol. Med. 33 (2002) 1615-1621
28. Chen A.S., Taguchi T., Sugiura M., Wakasugi Y., Kamei A., Wang M.W., and Miwa I. Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats. Horm. Metab. Res. 36 (2004) 183-187
29. +)-ATPase activity reduction in high glucose-treated human erythrocytes. Free Radic. Biol. Med. 30 (2001) 232-237